News

Children genetically predisposed to type 1 diabetes who consume bananas, oats, and yogurt may face a higher risk of developing...

On September 24, the Senate Health, Education, Labor, and Pensions Committee, chaired by Senator Bernie Sanders, will convene a highly...

In a significant breakthrough for diabetes care, researchers have made strides in treating type 1 diabetes mellitus (T1DM) using cutting-edge...

Food insecurity, defined as inconsistent access to adequate nutrition for maintaining an active, healthy life, has long been a challenge...

Abbott has officially launched its prescription-free continuous glucose monitor, Lingo, marking a significant step into the general wellness market. Cleared...

A recent study by researchers from Michigan State University (MSU) and South Shore Hospital offers promising news for patients with...

The Medicines and Healthcare products Regulatory Agency (MHRA) has determined that there is no evidence linking GLP-1 receptor agonists—a popular...

A new, extensive study has revealed that popular low-carbohydrate, high-fat diets could significantly increase the risk of developing type 2...

The Ministry of Health's (MOH) recent decision to subsidise up to 80% of the cost of continuous glucose monitoring (CGM)...

A groundbreaking new study highlights the benefits of the weight-loss drug Zepbound, originally developed to treat diabetes, in preventing the...

A recent study from the Karolinska Institutet in Sweden has uncovered that both type 2 diabetes and prediabetes can significantly...

Recent research suggests that dark chocolate could be a valuable addition to diets aiming to lower the risk of diabetes...

Embecta Corp. has achieved a significant milestone in diabetes care with the U.S. Food and Drug Administration (FDA) granting 510(k)...

Healthcare providers must evaluate both HbA1c and continuous glucose monitoring (CGM) metrics when managing diabetes, as neither metric alone can...

A new nationwide study reveals that patients with diabetes, particularly those with type 1, face significantly higher rates of sudden...

Be a part of the solution with Breakthrough T1D, the leading global organization dedicated to advancing research and support for...

A recent meta-analysis published in the International Journal of Obesity has demonstrated that Tirzepatide, a novel once-weekly medication, significantly outperforms...

Recent research published in The BMJ indicates that sodium-glucose cotransporter-2 (SGLT-2) inhibitors, a class of diabetes medication, may significantly reduce...

Recent research from the Centenary Institute reveals that specific blood fat markers can forecast how well individuals with pre-diabetes will...

MTPConnect is set to provide a significant boost to Australian small to medium enterprises (SMEs) focusing on innovations in the...